H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Census population 474,069. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Raleigh clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Raleigh storefront.
Orthobiologic Treatments for Your Practice in Raleigh, NC for clinics & physicians. Premium orthobiologic… Compliance support & pricing — contact Hawk Medical.
9.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Population 474,069. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JM documentation are ready before the first application of orthobiologic treatments.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)Three grains, kept separate on purpose. City: Census 474,069 and CDC PLACES crude rates. State: N.C. Department of Health & Human Services, Diabetes Belt counties present. Federal: 21 CFR 1271 and Palmetto GBA LCDs. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Raleigh trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 9.1% of adults — 2.9 points below the U.S. 12% figure. Obesity is 30.9%; arthritis is 19.8%. That is place-level BRFSS modeling, not a clinic census and not a Raleigh trial.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers orthobiologic treatments for your practice and which products they use.
North Carolina includes Diabetes Belt counties in CDC’s published geography. That supports a higher index of suspicion for DFU and chronic-wound volume. It is not a license to skip offloading, vascular assessment, or JM documentation.
North Carolina is JM. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
Bring specialty, monthly joint / regenerative volume, and whether you bill JM FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.1% diabetes and 19.8% arthritis for Raleigh — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Raleigh, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Raleigh is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Raleigh — 2.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Raleigh. Useful for joint-program math; still needs a diagnosis and privileging.
No Raleigh storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.